Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial.
Lancet (London, England) · 2022 · 207 citations · Ricardo Rojo
Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate-to-severe atopic dermatitis: Results from the JAK1 Atopic Dermatitis Efficacy and Safety (JADE) REGIMEN phase 3 trial.
Journal of the American Academy of Dermatology · 2022 · 126 citations · Ricardo Rojo
Brain stimulation and other biological non-pharmacological interventions in mental disorders: An umbrella review.
Neuroscience and biobehavioral reviews · 2022 · 93 citations · Georgios Petrides
Outcomes of electroconvulsive therapy in patients with depressive symptoms with versus without comorbid personality disorders/traits: A systematic review and meta-analysis.
Acta psychiatrica Scandinavica · 2024 · 16 citations · Georgios Petrides
Longitudinal Neurocognitive Effects of Combined Electroconvulsive Therapy (ECT) and Pharmacotherapy in Major Depressive Disorder in Older Adults: Phase 2 of the PRIDE Study.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2022 · 30 citations · Georgios Petrides
ECT-induced cognitive side effects are associated with hippocampal enlargement.
Translational psychiatry · 2021 · 47 citations · Georgios Petrides
Pathophysiology of Angiotensin II-Mediated Hypertension, Cardiac Hypertrophy, and Failure: A Perspective from Macrophages.
Cells · 2024 · 15 citations · Eshan Shah
Electroconvulsive therapy-induced volumetric brain changes converge on a common causal circuit in depression.
Molecular psychiatry · 2024 · 14 citations · Georgios Petrides